Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were diagnosed with advanced non-small cell lung cancer (a type of lung cancer) between January 1, 2011, and June 30, 2024.
- People whose medical records can be followed up until at least December 31, 2024, with at least six months of information available after diagnosis.
Who may not be able to join:
- People who have less than one full day of medical follow-up recorded after starting their first round of treatment.
- People whose cancer has a specific genetic change (mutation) in any of the following genes: ALK, BRAF, EGFR, KRAS, or ROS1.
- People whose cancer tested below 50% for a protein called PD-L1 — this trial focuses on cases where PD-L1 levels were 50% or higher (confirm with trial site).
- People whose first treatment was anything other than immunotherapy or a combination of chemotherapy and immunotherapy — other treatment types are not included in this trial (confirm with trial site).
- People who have already received a second round of treatment for their cancer, including those who took part in another clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.